160 related articles for article (PubMed ID: 24800883)
1. Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD, a longitudinal and cross-sectional study.
Chang C; Zhu H; Shen N; Chen Y; He B; Zhao J; Yao W
COPD; 2015 Feb; 12(1):19-30. PubMed ID: 24800883
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD.
Wang JX; Li HQ; Zhang F; Ning W
Int J Chron Obstruct Pulmon Dis; 2019; 14():1923-1932. PubMed ID: 31692553
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD.
Scherr A; Graf R; Bain M; Christ-Crain M; Müller B; Tamm M; Stolz D
Chest; 2013 Feb; 143(2):379-387. PubMed ID: 22922487
[TBL] [Abstract][Full Text] [Related]
6. Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease.
Liang Y; Chang C; Zhu H; Shen N; He B; Yao W
Intern Emerg Med; 2015 Sep; 10(6):685-91. PubMed ID: 25822151
[TBL] [Abstract][Full Text] [Related]
7. Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers.
Jing Z; Chun C; Ning S; Hong Z; Bei H; Wan-Zhen Y
Arch Bronconeumol; 2016 Mar; 52(3):138-44. PubMed ID: 26002550
[TBL] [Abstract][Full Text] [Related]
8. Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test.
Dai MY; Qiao JP; Xu YH; Fei GH
Int J Chron Obstruct Pulmon Dis; 2015; 10():2257-63. PubMed ID: 26527871
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples.
Alotaibi NM; Chen V; Hollander Z; Leipsic JA; Hague CJ; Murphy DT; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
Int J Chron Obstruct Pulmon Dis; 2019; 14():311-319. PubMed ID: 30774328
[TBL] [Abstract][Full Text] [Related]
10. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
11. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
12. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae urinary antigen test and acute exacerbations of chronic obstructive pulmonary disease.
Nishimura K; Nishimura T; Oga T
COPD; 2012 Aug; 9(4):344-51. PubMed ID: 22452423
[TBL] [Abstract][Full Text] [Related]
15. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial.
Osadnik CR; McDonald CF; Miller BR; Hill CJ; Tarrant B; Steward R; Chao C; Stodden N; Oliveira CC; Gagliardi N; Holland AE
Thorax; 2014 Feb; 69(2):137-43. PubMed ID: 24005444
[TBL] [Abstract][Full Text] [Related]
16. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
Jiang M; Ma JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship between airway bacterial infections and acute exacerbations in patients with chronic obstructive pulmonary disease].
Zhou YQ; Xie CM; Chen DM; Chen L
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):503-6. PubMed ID: 17877185
[TBL] [Abstract][Full Text] [Related]
18. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD.
Ko FW; Ip M; Chan PK; Fok JP; Chan MC; Ngai JC; Chan DP; Hui DS
Chest; 2007 Jan; 131(1):44-52. PubMed ID: 17218555
[TBL] [Abstract][Full Text] [Related]
19. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
Soler N; Esperatti M; Ewig S; Huerta A; Agustà C; Torres A
Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
